GILT—A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00066-016-0941-8
Published Online: 2016-01-25
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Flentje, Michael
Huber, Rudolf M.
Engel-Riedel, Walburga
Andreas, Stefan
Kollmeier, Jens
Staar, Susanne
Dickgreber, Nicolas
Vaissiere, Nathalie
De Almeida, Cecilia
Edlich, Birgit
Fietkau, Rainer
Text and Data Mining valid from 2016-01-25